Team
Newton Biocapital is managed by life sciences entrepreneur Alain Parthoens. He and his team of experienced industry and venture capital professionals leverage their strategic insights to create value for both patients and investors.
Operational
Alain
Parthoens
ir / Managing Partner & Founder
- 20 years in the food and biotech industries (Nestle, Monsanto/Searle, PWC)
- 15 years of venture capital (ING Bank, Vesalius Biocapital)
- 30 investments in early and neglected late-stage companies, typically as lead investor
- Director of Ogeda, Promethera Biosciences, Profibrix, Voluntis, NCardia (ex-Pluriomics) and Epics Therapeutics
- Formerly Chairman of the BVA and member of the Invest Europe VC council
- Based in Brussels
Els
Hubloux
ir / MBA
Representative Global Investments Europe
Partner
- 19 years in clinical R&D, financial analysis, and management
- 14 years in venture capital (KBCPE, Capricorn Venture Partners, QBIC Venture Partners)
- Over 20 transactions in small biotechs, several IPOs and trade sales
- Based in Brussels
Guy
Heynen
MD
Clinical & Regulatory Director
Partner
- Chief Clinical and Regulatory Officer of Bone Therapeutics (regenerative medicine)
- Joined Pfizer in 1982; served as Medical Director for Pfizer Switzerland and as International Medical Director up to 2000, and as Regional Medical monitor for Pfizer up to 2014.
- Independent Director of Ogeda and Pluriomics
Danny
Gonnissen
PhD Appl. Sc. / COO
Partner
- 13 years in industry
- 8 years of venture capital (Bekaert Venturing, Qbic Fund) with expertise in Direct Investments and Fund Investments
- Board seats in start-ups & scale-ups
- Based in Brussels
Sadashi Suzuki
Representative Global Investments Japan
- Carry wealth of operation and management experiences and expertise in healthcare industry for 40 years (Kyowa-Kirin, Baxter, Affymetrix, Bio-Rad, and Cepheid)
- Expertise in international business from the experience of management of foreign affiliated subsidiaries in Japan as a country head.
- Having been advisor and mentor to life science start-ups both in Japan and overseas
- BA in Law from Waseda University, MBA from J.L.Kellogg School of Management, Northwestern University.
- Based in Tokyo
Pierre
Detrixhe
ir / Master in Management
Investment Director
- Background in bio-engineering with previous experience as a scientist in biotech and a technology transfer officer
- More than 10 years in venture capital (Investsud Group)
- 10 investments in early stage companies
- Director at ATB Therapeutics, Bioxodes, Synergia Medical
- Based in Brussels
Yao Li
BS/MBA
Investment Director
- 13 years in the financial industry and banking services
- Various cross-border M&A experiences with deal size over 2 Billion USD
- Based in Tokyo
Tomoko Asaoka
PhD
Investment Director Clinical & Regulatory
- 14 years in academic research, specialized in the fundamental and translational aspects of cancer and immunology
- Joined Newton Biocapital in 2021
- Based in Brussels
Kinji Fuchikami
Dario
Padovani
BS CS / EMM
CFO
- 20 years in the chemical industry (Monsanto, Searle)
- 11 years in insurance industry, 8 years in the distribution & logistics industries
- Based in Brussels
Toko Senna
Office Manager Brussels
- Based in Brussels
Noriko Krook
Office Manager Tokyo
- Based in Tokyo
Louis
de Thanhoffer
de Völcsey
Senior Pharma
Biotech Advisor
- Started his career as a research scientist at the Pasteur Institute and in Pr. Dr. Walter Fiers' Lab of Molecular Biology at the State University of Ghent (Belgium)
- Joined Janssen Pharmaceutica in 1983 at the request of Dr. Paul Janssen to create the Lab of Molecular Genetics in the Janssen Life Sciences Department
- In 2000, set up a healthcare/biotech team at Petercam, a Brussels-based stockbrokerage firm (noz Degroof Petercam Bank)
- From 2008 until 2013, he joined Hunza Ventures, a life sciences private equity fund that belongs to a family office
Independent Board Directors
Ajit
Shetty
Chairman
Independent director
- Formerly CEO, Chairman of Janssen Pharmaceutica
- Vice President Enterprise Supply Chain for Johnson & Johnson
Dirk
Boogmans
Vice-Chairman
Independent director
- CEO of construction group CFE (1998 - 2001), CEO of GIMV (2001-2008)
- Board of Director member at BNP Paribas Fortis (Since 2009)
Dr. Michihiko Wada MD
- Medical Doctor, PhD.of Kyoto Univ. with surgical (oncology) and research responsibility (Kobe City General hospital), alternating with Head of R&D in the pharmaceutical industry
- Presently professor at the Keio University hospital, in charge of the Clinical and Translational Research Center, Tokyo
Robert Hirst
- Longtime chairman of Fintech Global Inc.(FGI), a boutique investment bank listed on the TSE, and presently Senior Advisor to FGI
- Executive chairman of Moomin Monogatari K.K., the company running the Moomin Valley Theme Park in Hanno township, Saitama
Jean-Claude
Deschamps
Chairman Emeritus
- Substantial industrial and venture capital experience
- Instrumental in founding several worldwide recognized projects, including IMEC
Founders
Alain
Parthoens
Goro
Takeda